Authors: Ilya Klabukov
The dramatic development of biomedical technologies inevitably raises a question of the increasing “gap” between basic biomedical discoveries and their use in clinical practice. Created in 1958 with the same purpose, DARPA has had to bridging the gap in defense technologies (mostly in rocket and radar sciences). Today we can talk about the relevance of the idea of “biomedical DARPA” (BioDARPA) as a concept of organizational design for priority research and development of emerging biotechnologies.
Comments: 12 Pages.
[v1] 2018-02-01 11:45:52
Unique-IP document downloads: 6 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.